Dapagliflozin DPPIV Inhibitor add-on Study

Part of paid clinical trials in Huntsville, Alabama.

Sponsor
AstraZeneca
Study ID
NCT00984867
Phase
PHASE3
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Dapagliflozin — DRUG
    10 mg tablet, oral, once daily, 48 weeks
  • Placebo — DRUG
    Matching placebo tablet

Study Details

This study aims to investigate how dapagliflozin can control blood sugar in patients with type 2 diabetes when added to existing treatments (sitagliptin alone or in combination with metformin). The effect of dapagliflozin on weight and blood pressure will also be studied.

Key Dates

Start date
Oct 31, 2009
Status verified
Jun 2014
Primary completion
Mar 31, 2011
Completion
Sep 30, 2011

Study Design

Enrollment
833 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: 1
    Dapagliflozin 10 mg tablet
  • Placebo Comparator: 2
    Matching placebo tablet

Primary Outcome Measure

Adjusted Mean Change in HbA1c Levels [ Time Frame: Baseline to Week 24 ]

Locations (45)

FacilityCityStateZIPSite coordinators
Research SiteHuntsvilleAlabama--
Research SiteOzarkAlabama--
Research SiteAnaheimCalifornia--
Research SiteChula VistaCalifornia--
Research SiteGreenbraeCalifornia--
Research SiteLaguna HillsCalifornia--
Research SiteLos AngelesCalifornia--
Research SiteRiversideCalifornia--
Research SiteWest HillsCalifornia--
Research SiteBoca RatonFlorida--
Research SiteDeLandFlorida--
Research SiteJacksonvilleFlorida--
Research SiteLongwoodFlorida--
Research SiteMiamiFlorida--
Research SitePort OrangeFlorida--
Research SiteWest Palm BeachFlorida--
Research SiteStone MountainGeorgia--
Research SiteWichitaKansas--
Research SiteLake CharlesLouisiana--
Research SiteEdinaMinnesota--
Research SiteSt LouisMissouri--
Research SiteLas VegasNevada--
Research SitePahrumpNevada--
Research SiteStaten IslandNew York--
Research SiteWilmingtonNorth Carolina--
Research SiteCincinnatiOhio--
Research SiteColumbusOhio--
Research SiteDaytonOhio--
Research SiteOklahoma CityOklahoma--
Research SiteMedordOregon--
Research SiteLancasterPennsylvania--
Research SitePhiladelphiaPennsylvania--
Research SiteMt. PleasantSouth Carolina--
Research SiteMyrtle BeachSouth Carolina--
Research SiteSimpsonvilleSouth Carolina--
Research SiteBristolTennessee--
Research SiteCorpus ChristiTexas--
Research SiteDallasTexas--
Research SiteNorth Richland HillsTexas--
Research SiteSan AntonioTexas--
Research SiteSalt Lake CityUtah--
Research SiteBurkeVirginia--
Research SiteManassasVirginia--
Research SiteRichmondVirginia--
Research SiteLakewoodWashington--

Find similar trials in Huntsville, AL

By condition
Type 2 diabetes
By specialty
EndocrinologyMetabolic healthWeight loss
By research site
Research Site· Huntsville, ALResearch Site· Ozark, ALResearch Site· Anaheim, CAResearch Site· Chula Vista, CAResearch Site· Greenbrae, CAResearch Site· Laguna Hills, CA

Related Studies